High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)
Clinical trial NCT04247633 · UNKNOWN
Trial details
- NCT number
- NCT04247633
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2023-02-01
- Enrollment
- 578
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.